Global Locations

Deschloro Empagliflozin



Chemical Properties of 'Deschloro Empagliflozin'

CAT No. :

CS-O-12084
Parent API : Empagliflozin
CAS Registry No. : 2452301-27-6
Category : Metabolites
Molecular Weight: 416.46
Molecular Formula : C23H28O7
Controlled Substance : NO
Purity : Not less than 90%
Therapeutic : Anti-Diabetic
Appearance : Light green sticky solid
Synonyms : Empagliflozin M418;(2R;3S;4R;5R;6S)-2-(hydroxymethyl)-6-(3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)tetrahydro-2H-pyran-3;4;5-triol;(2R;3S;4R;5R;6S)-2-(hydroxymethyl)-6-(3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)tetrahydro-2H-pyran-3;4;5-triol;Empagliflozin M418.
Application : Impurity in commercial preparations of Empagliflozin.
References : "Thomas; L,; et al,: Diabetes, Obesity, Metabol, 14; 94 (2012); Grempler; R,; et al,: Diabetes, Obesity, Metabol,; 14; 83 (2012);"
Custom Duty : Applicable
Documents:  View Sample COA   View Sample MSDS
Port of Loading : Canada
Expected Dispatch : 13-Aug-2022
Taxes : Not Applicable
Refund Policy : 30-days money back


More information about Deschloro Empagliflozin


Empagliflozin, sold under the brand name Jardiance among others, is an antidiabetic medication used to improve glucose control in people with type 2 diabetes, used to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease, used to reduce the risk of death and hospitalization in people with heart failure and low ejection fraction, and used to reduce the risk of cardiovascular death and hospitalization for heart failure in adults. It can be prescribed instead of metformin and has benefits over sulfonylureas. It may be used together with other medications such as metformin or insulin. It is not recommended for type 1 diabetes. It is taken by mouth.

Common side effects include urinary tract infections, fungal infections of the groin, and joint pains. Rarer but more serious side effects include a skin infection of the groin called Fournier's gangrene and a form of diabetic ketoacidosis with normal blood sugar levels. Use in pregnancy and breastfeeding is not recommended. Use is not recommended in those with significant kidney disease, though it may help slow the progression of mild kidney problems. Empagliflozin is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), and works by increasing sugar lost in the urine.

Empagliflozin was approved for medical use in the United States and in the European Union in 2014. It is on the World Health Organization's List of Essential Medicines. In 2019, it was the 146th most commonly prescribed medication in the United States, with more than 4\u00a0million prescriptions.



This page contains information about Deschloro Empagliflozin , Deschloro Empagliflozin cas, Deschloro Empagliflozin synthesis, Deschloro Empagliflozin suppliers

What is Deschloro Empagliflozin ?
Deschloro Empagliflozin falls under Metabolites of Empagliflozin.Impurity in commercial preparations of Empagliflozin.
What is the CAS Number of Deschloro Empagliflozin?
The CAS Number of Deschloro Empagliflozin is 2452301-27-6
Who are the suppliers of Deschloro Empagliflozin?
CLEARSYNTH is a worldwide supplier of Deschloro Empagliflozin

List of Empagliflozin Metabolites

Related compounds of Deschloro Empagliflozin

Looking for a discounted price or need more info for 'Deschloro Empagliflozin (CS-O-12084)' ?

If you are looking for Bulk purchase, Discounted Price, etc. please share your email and the exact quantity you are looking for, our team will respond to you within 30 mins with all the required information.

Looking for a discounted price or need more info for 'Deschloro Empagliflozin (CS-O-12084)' ?

If you are looking for Bulk purchase, Discounted Price, etc. please share your email and the exact quantity you are looking for, our team will respond to you within 30 mins with all the required information.